Yep. If you've been following the changes at the FDA an accelerated approval definitely a possibility in this one. The FDA is to its credit trying to improve the laboured process of its approvals in novel biologics for chronic illnesses where patients face a very poor prognosis under standard of care. Far too mnay amputations globally for DFU. This one is crying for out an AA.
Ann: DFU Clinical Trial Enrolment Complete, page-7
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.23M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11654 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 1355 | 1 |
View Market Depth
| Last trade - 11.00am 02/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable